Shan L, Leung K, Zhang H, Cheng KT, Pagel M (2004) Molecular imaging and contrast agent database (MICAD). Bethesda, MD: National Center for Biotechnology Information

Xu Z, Li X-F, Zou H et al (2017) 18F-Fluoromisonidazole in tumor hypoxia imaging. Oncotarget 8(55):94969

Article  PubMed  PubMed Central  Google Scholar 

Grönroos T, Bentzen L, Marjamäki P et al (2004) Comparison of the biodistribution of two hypoxia markers [18 F] FETNIM and [18 F] FMISO in an experimental mammary carcinoma. Eur J Nucl Med Mol Imaging 31:513–520

Article  PubMed  Google Scholar 

Komar G, Lehtiö K, Seppänen M et al (2014) Prognostic value of tumour blood flow, [18 F] EF5 and [18 F] FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy. Eur J Nucl Med Mol Imaging 41:2042–2050

Article  CAS  PubMed  Google Scholar 

Sanduleanu S, van der Wiel AM, Lieverse RI et al (2020) Hypoxia PET imaging with [18F]-HX4—a promising next-generation tracer. Cancers (Basel) 12(5):1322

Article  CAS  PubMed  Google Scholar 

Jans H-S, Yang X-H, Brocks DR et al (2018) Positron emission tomography (PET) and pharmacokinetics: classical blood sampling versus image-derived analysis of [18F] FAZA and [18F] FDG in a murine tumor bearing model. J Pharm Pharm Sci 21(1s):32s–47s

Article  CAS  PubMed  Google Scholar 

Carlin S, Zhang H, Reese M et al (2014) A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers. J Nucl Med 55(3):515–521

Article  CAS  PubMed  Google Scholar 

Nocentini A, Supuran C (2018) Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018). Expert Opin Ther Pat 28(10):729–740

Article  CAS  PubMed  Google Scholar 

Mahon BP, Pinard MA, McKenna RJM (2015) Targeting carbonic anhydrase IX activity and expression. Molecules 20(2):2323–2348

Article  PubMed  PubMed Central  Google Scholar 

Kessenbrock K, Plaks V, Werb ZJC (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52–67

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hilvo M, Baranauskiene L et al (2008) Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes. J Biol Chem 283(41):27799–27809

Article  CAS  PubMed  Google Scholar 

Supuran CT (2018) Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Exp Opin Investigat Drugs 27(12):963–70

Article  CAS  Google Scholar 

Divgi CR, Pandit-Taskar N, Jungbluth AA et al (2007) Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol 8(4):304–310

Article  CAS  PubMed  Google Scholar 

Divgi CR, Uzzo RG, Gatsonis C et al (2013) Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. J Clin Oncol 31(2):187–194

Article  PubMed  Google Scholar 

Reilly RM, Lam K, Chan C et al (2015) Advancing novel molecular imaging agents from preclinical studies to first-in-humans phase I clinical trials in academia- a roadmap for overcoming perceived barriers. Bioconjug Chem 26(4):625–632

Article  CAS  PubMed  Google Scholar 

Turkbey B, Lindenberg ML, Adler S et al (2016) PET/CT imaging of renal cell carcinoma with 18 F-VM4-037: a phase II pilot study. Abdom Radiol (NY) 41:109–118

Article  PubMed  Google Scholar 

Peeters SG, Dubois L, Lieuwes NG et al (2015) [18 F] VM4-037 microPET imaging and biodistribution of two in vivo CAIX-expressing tumor models. Mol Imaging Biol 17:615–619

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang X, Zhu H, Yang X et al (2019) Targeting CAIX with [64Cu] XYIMSR-06 small molecular radiotracer enables noninvasive PET imaging of malignant glioma in U87 MG tumor cell xenograft mice. Mol Pharm 16(4):1532–1540

Article  CAS  PubMed  Google Scholar 

Minn I, Koo SM, Lee HS et al (2016) [64Cu] XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma. Oncotarget 7(35):56471

Article  PubMed  PubMed Central  Google Scholar 

Yang X, Minn I, Rowe S et al (2015) Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor. Oncotarget 6:33733–33742

Article  PubMed  PubMed Central  Google Scholar 

Varia MA, Calkins-Adams DP, Rinker LH et al (1998) Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol 71(2):270–277

Article  CAS  PubMed  Google Scholar 

Tharmalingham H, Hoskin P (2018) Clinical trials targeting hypoxia. British J Radiol 92(1093):20170966

Article  Google Scholar 

Krall N, Pretto F, Mattarella M et al (2016) A 99mTc-labeled ligand of carbonic anhydrase IX selectively targets renal cell carcinoma in vivo. J Nuclear Medic 57(6):943–949

Article  CAS  Google Scholar 

Kulterer OC, Pfaff S, Wadsak W et al (2021) A microdosing study with 99mTc-PHC-102 for the SPECT/CT imaging of primary and metastatic lesions in renal cell carcinoma patients. J Nuclear Medic 62(3):360–365

Article  CAS  Google Scholar 

Zhu W, Li X, Zheng G et al (2023) Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging 50(10):3116–3125

Article  CAS  PubMed  Google Scholar 

Hofman MS, Tran B, Feldman DR et al (2024) First-in-human safety, imaging, and dosimetry of a carbonic anhydrase IX–Targeting Peptide,[68Ga] Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma. J Nuclear Medic 65(5):740–743

Article  CAS  Google Scholar 

Li N, Zhu H, Chu T-w et al (2013) Preparation and biological evaluation of 99mTc-N4IPA for single photon emission computerized tomography imaging of hypoxia in mouse tumor. Eur J Med Chem 69:223–231

Article  CAS  PubMed  Google Scholar 

Staffurth J (2010) A review of the clinical evidence for intensity-modulated radiotherapy. Clinic Oncol 22(8):643–57

Article  Google Scholar 

Massière F, Wiedemann N, Borrego I et al (2024) Preclinical characterization of DPI-4452: a 68Ga/177Lu theranostic ligand for carbonic anhydrase IX. J Nucl Med 65(5):761–767

Article  PubMed  PubMed Central  Google Scholar